Skip to main content
Year archive

Brainsway Ltd. — 2025 filings

All 49 regulatory filings released by Brainsway Ltd. (BWAY) in 2025, sourced directly from the official regulator.

49 Filings
2025 Period
2025 filings (49)
Filing Released Lang
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
Regulatory Filings
2025-12-22 English
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
Report Publication Announcement
2025-12-22 English
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder
Regulatory Filings
2025-11-17 English
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder
Report Publication Announcement
2025-11-17 English
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
Regulatory Filings
2025-11-13 English
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
Report Publication Announcement
2025-11-13 English
BrainsWay November 2025 Investor Presentation
Investor Presentation
2025-11-12 English
BrainsWay November 2025 Investor Presentation
Report Publication Announcement
2025-11-12 English
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
Earnings Release Q3 2025
2025-11-12 English
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
Report Publication Announcement
2025-11-12 English
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
Earnings Release Q3 2025
2025-11-11 English
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
Report Publication Announcement
2025-11-11 English
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder
Regulatory Filings
2025-11-04 English
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder
Report Publication Announcement
2025-11-04 English
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
Regulatory Filings
2025-10-27 English
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
Report Publication Announcement
2025-10-27 English
Immediate Report
Regulatory Filings
2025-10-14 English
Immediate Report
Capital/Financing Update
2025-10-14 English
Report of Periodic or Interim Report
Interim / Quarterly Report H1 2025
2025-10-01 English
Report of Periodic or Interim Report
Report Publication Announcement
2025-10-01 English
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
Regulatory Filings
2025-09-16 English
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
Report Publication Announcement
2025-09-16 English
Immediate Report
Declaration of Voting Results & Voting Rights Announcements
2025-09-12 English
Immediate Report
Report Publication Announcement
2025-09-12 English
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
Regulatory Filings
2025-08-21 English
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
Regulatory Filings
2025-08-21 English
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
Regulatory Filings
2025-08-20 English
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
M&A Activity
2025-08-20 English
Corporate Presentation
Investor Presentation
2025-08-13 English
Corporate Presentation
Report Publication Announcement
2025-08-13 English
Reports Second Quarter 2025 Financial Results and Operational Highlights
Earnings Release Q2 2025
2025-08-13 English
Reports Second Quarter 2025 Financial Results and Operational Highlights
Report Publication Announcement
2025-08-13 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2025-08-07 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2025-08-07 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2025-08-07 English
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
Regulatory Filings
2025-06-11 English
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
Report Publication Announcement
2025-06-11 English
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
Capital/Financing Update
2025-06-04 English
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
Capital/Financing Update
2025-06-04 English
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
Interim / Quarterly Report Q1 2025
2025-05-13 English
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
Report Publication Announcement
2025-05-13 English
FORM F-3 - REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Capital/Financing Update
2025-04-23 English
FORM F-3 - REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Report Publication Announcement
2025-04-23 English
Form 20-F for the Year Ended December 31, 2024
Annual Report FY 2024
2025-04-22 English
Form 20-F for the Year Ended December 31, 2024
Report Publication Announcement
2025-04-22 English
FORM 6-K-Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Earnings Release Q4 2024
2025-03-11 English
FORM 6-K-Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Earnings Release FY 2024
2025-03-11 English
SCHEDULE 13G-Avner Hagai
Major Shareholding Notification
2025-01-29 English
SCHEDULE 13G-Avner Hagai
Report Publication Announcement
2025-01-29 English